• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[绝经后子宫内膜增生性病变患者使用抗雌激素治疗的发病机制基础]

[The pathogenetic basis for using antiestrogens in treating patients with hyperplastic processes of the endometrium in the postmenopause].

作者信息

Vysotskiĭ M M, Krasnova I A, Kostyleva O I, Eremin V L

出版信息

Akush Ginekol (Mosk). 1993(6):46-9.

PMID:8311159
Abstract

Estradiol and progesterone cytosol receptors, tamoxifen relative binding capacity in endometrial tissue samples, serum estradiol and progesterone levels were studied in 60 postmenopausal patients with hyperplastic processes in the endometrium. Estradiol and progesterone receptor levels were increased in glandular cystic polyp tissue, in atypical hyperplastic tissue samples, and in well-differentiated adenocarcinoma tissue. High estradiol levels were detected in the blood sera of patients with glandular cystic polyps, atypical and glandular hyperplasia. Tamoxifen relative binding capacity was the highest in glandular cystic polyps and glandular hyperplasia. Forty patients were treated with 17-hydroxyprogesterone capronate. The data on the status of cytosol receptors and tamoxifen relative binding capacity as well as clinical findings give grounds to include antiestrogens into therapeutic complex for postmenopausal patients with endometrial hyperplasia.

摘要

对60例绝经后子宫内膜增生患者的子宫内膜组织样本中的雌二醇和孕酮胞浆受体、他莫昔芬相对结合能力、血清雌二醇和孕酮水平进行了研究。在腺囊性息肉组织、非典型增生组织样本和高分化腺癌组织中,雌二醇和孕酮受体水平升高。在腺囊性息肉、非典型增生和腺性增生患者的血清中检测到高雌二醇水平。他莫昔芬相对结合能力在腺囊性息肉和腺性增生中最高。40例患者接受了己酸17-羟孕酮治疗。关于胞浆受体状态、他莫昔芬相对结合能力的数据以及临床发现为将抗雌激素纳入绝经后子宫内膜增生患者的治疗方案提供了依据。

相似文献

1
[The pathogenetic basis for using antiestrogens in treating patients with hyperplastic processes of the endometrium in the postmenopause].[绝经后子宫内膜增生性病变患者使用抗雌激素治疗的发病机制基础]
Akush Ginekol (Mosk). 1993(6):46-9.
2
Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.绝经后接受他莫昔芬治疗的子宫内膜病变中雌激素和孕激素受体的表达
Gynecol Oncol. 1997 Oct;67(1):8-15. doi: 10.1006/gyno.1997.4831.
3
[The estrogen receptors of the endometrial plasma membranes in proliferative processes in the postmenopause].[绝经后期增殖过程中子宫内膜质膜的雌激素受体]
Akush Ginekol (Mosk). 1989 Dec(12):60-3.
4
Effects of hormone therapy on the endometrium.激素疗法对子宫内膜的影响。
Mod Pathol. 1993 Jan;6(1):94-106.
5
[Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].[子宫内膜增生过程中甾体激素受体表达的免疫组织化学研究]
Arkh Patol. 2004 Mar-Apr;66(2):7-10.
6
Hormonal receptors in endometrial neoplasias.
Eur J Gynaecol Oncol. 1988;9(5):396-8.
7
Relative binding activity of new antigestagens with progesterone receptors in human hyperplastic endometrium.新型抗孕激素与人类增生期子宫内膜中孕激素受体的相对结合活性
Bull Exp Biol Med. 2002 Nov;134(5):445-7. doi: 10.1023/a:1022682028745.
8
Antioxidant status and sex hormones in women with complex endometrial hyperplasia.复杂子宫内膜增生女性的抗氧化状态与性激素
Cell Mol Biol (Noisy-le-grand). 2016 Sep 30;62(11):51-56.
9
[Serum E2 and progesterone levels in patients with atypical hyperplasia and endometrial carcinoma].
Akush Ginekol (Sofiia). 1993;32(2):23-4.
10
Progesterone binding by human endometrial tissue during the proliferative and secretory phases of the menstrual cycle and by hyperplastic and carcinomatous endometrium.在月经周期的增殖期和分泌期,人子宫内膜组织以及增生性和癌性子宫内膜对孕酮的结合情况。
Am J Obstet Gynecol. 1979 Mar 15;133(6):660-5. doi: 10.1016/0002-9378(79)90015-2.